Patents Examined by Ganapathirama Raghu
  • Patent number: 11319565
    Abstract: The disclosure discloses a method for preparing a lipoamino acid compound based on deep eutectic solvents, and belongs to the field of organic synthesis. The preparation method of the disclosure uses a fatty acid and an amino acid as substrates, uses a deep eutectic solvent as a medium, and directly and efficiently prepares a single-chain lipoamino acid surfactant under the catalysis of lipase CALB. Alternatively, Amano lipase M is used as a catalyst to efficiently catalyze the reaction of an amino acid containing a plurality of amino groups with a fatty acid to prepare a Gemini amino acid. The method of the disclosure does not need to undergo protection and deprotection of the amino acid, and does not involve commonly used fatty acid chlorides. Compared with the traditional chemical synthesis methods, the disclosure has the advantages of greenness, safety, high selectivity, high yield, etc., and has very important potential application value.
    Type: Grant
    Filed: December 31, 2020
    Date of Patent: May 3, 2022
    Assignee: Jiangnan University
    Inventors: Yuanfa Liu, Binbin Nian, Chen Cao, Zhaojun Zheng, Yongjiang Xu, Yinghong Zhai
  • Patent number: 11312983
    Abstract: Green preparation methods of rice resistant starch are disclosed. In some embodiments, a green preparation method of the rice resistant starch is characterized in that, at a temperature lower than the gelatinization temperature, the rice starch is sequentially modified by enzymes using ?-amylase, glucosidase, and pullulanase to obtain the modified starch. In other embodiments, a green preparation method of the rice resistant starch is characterized by using: rice starch as a substrate; and in turn using: (a) ?-amylase (BA, EC 3.2.1.2) from barley (Hordeum vulgare); (b) glucoside transferase (TG, EC 2.4.1.24) from Aspergillus niger; and (c) pullulanase (PUL, EC 3.2.1.41) from Pullulanibacillus konaensis below a gelatinization temperature to modify a chain structure of the rice starch, resulting in a number of short linear chains which are effectively arranged, aggregated, and recrystallized at 4° C. to form modified rice starch with high resistant starch content.
    Type: Grant
    Filed: April 16, 2020
    Date of Patent: April 26, 2022
    Assignee: Qilu University of Technology
    Inventors: Li Guo, Hui Li, Bo Cui
  • Patent number: 11312753
    Abstract: Embodiments of the invention are generally directed to lignin-modifying enzymes and systems and methods of their manufacture. In many embodiments, the lignin-modifying enzymes are lignin-degrading enzymes capable of breaking down lignin into component parts that are usable for other purposes. Several embodiments are directed to systems for producing lignin-modifying enzymes in vivo, including in yeast and/or plant species, and certain embodiments are directed to methods of creating these systems, including transfecting the species to produce lignin-modifying enzymes.
    Type: Grant
    Filed: September 25, 2019
    Date of Patent: April 26, 2022
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Nikita A. Khlystov, Elizabeth Sattely
  • Patent number: 11306300
    Abstract: The present invention provides a transformed microorganism capable of displaying ?-galactosidase on its surface layer. Also provided is a method for producing an alcohol, which includes the step of culturing the transformed microorganism in a culture medium containing a material that contains an oligosaccharide ?-1,6 linked ?-galactose. Also provided is a method for producing lactic acid using such a transformed microorganism together with a material that contains an oligosaccharide ?-1,6 linked ?-galactose. According to the present invention, a microorganism can be provided, which can degrade an oligosaccharide containing ?-1,6 linked ?-galactose, which may occur in soybean molasses.
    Type: Grant
    Filed: May 10, 2018
    Date of Patent: April 19, 2022
    Assignees: KANSAI CHEMICAL ENGINEERING CO., LTD., BIO-ENERGY CORPORATION
    Inventors: Hideo Noda, Shinji Hama
  • Patent number: 11306330
    Abstract: The invention is directed to an engineered yeast including an exogenous nucleic acid encoding a glucoamylase comprising SEQ ID NO:1 and SEQ ID NO:4, or a variant thereof. The engineered yeast are able to provide glucoamylase into a fermentation media and cause degradation of starch material generating glucose for fermentation to a desired bioproduct, such as ethanol. High titers of bioproduct (e.g., 70 g/kg of ethanol) can be achieved, along with low residual glucose levels. Further the yeast exhibit good growth and bioproduct product at temperatures of 32° C. or greater.
    Type: Grant
    Filed: February 27, 2019
    Date of Patent: April 19, 2022
    Assignee: CARGILL, INCORPORATED
    Inventors: Chris Miller, Brian Rush, Brynne Stanton, Joshua Dunn
  • Patent number: 11299758
    Abstract: The invention relates to a process for treating lignocellulosic biomass by means of an acidic liquor in order to produce “second-generation” (2G) sugary liquors. These sugary liquors may be used to produce other products via a biochemical pathway (e.g. alcohols such as ethanol, butanol or other molecules, for example solvents such as acetone, etc.). This process comprises analysis of the liquid streams withdrawn during the process and adjustment of the composition of the impregnation liquor so as to keep the acidic power of said streams constant.
    Type: Grant
    Filed: December 4, 2018
    Date of Patent: April 12, 2022
    Assignees: IFP Energies nouvelles, AGRO INDUSTRIES RECHERCHE ET DEVELOPPEMENT, INSTITUTE NATIONAL DE RECHERCHE POUR L'AGRICULTURE L'ALIMENTATION ET L'ENVIRONNEMENT
    Inventors: Caroline Aymard, Pierre-Antoine Bouillon, Romain Rousset, Olivier Carnnot
  • Patent number: 11299757
    Abstract: This invention is intended to improve the ethanol fermentation ability of a yeast strain having xylose-metabolizing ability with the use of a mutant gene encoding a mutant protein comprising a consensus sequence comprising a substitution of amino acid in the 30th position in SEQ ID NO: 1, amino acid in the 43rd position in SEQ ID NO: 4, and amino acid in the 31st position in SEQ ID NO: 7 with other amino acid residues.
    Type: Grant
    Filed: November 5, 2018
    Date of Patent: April 12, 2022
    Assignee: TOYOTA JIDOSHA KABUSHIKI KAISHA
    Inventors: Junji Ito, Toru Onishi, Nobuki Tada, Rie Hirao
  • Patent number: 11293015
    Abstract: The present invention provides a Diels-Alderase and use thereof, and belongs to the field of gene engineering technology. The Diels-Alderase is MaDA, and its amino acid sequence and gene sequence are represented by SEQ ID Nos. 1 and 2, respectively. The present invention also provides MaDA-1 and MaDA-2, both of which are homologous proteins of MaDA, and their amino acid sequences are represented by SEQ ID Nos. 10 and 12, respectively. The present invention has discovered that MaDA and its homologous proteins from Morus alba can stereospecifically synthesize natural products of endo configuration, and prepare D-A type natural products and their analogs in vitro using chalcones and dehydroprenyl-containing compounds as substrates, which helps to develop and utilize the medicinal value of such natural products, and also provides a possibility to synthesize other six-membered ring-containing important chemical precursors or natural products.
    Type: Grant
    Filed: November 18, 2020
    Date of Patent: April 5, 2022
    Assignees: Peking University, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College
    Inventors: Xiaoguang Lei, Jungui Dai, Lei Gao, Cong Su
  • Patent number: 11293027
    Abstract: The present invention provides a recombinant Bacillus subtilis with improved 2?-fucosyllactose production, and a construction method thereof. In the present invention, a strain capable of efficiently synthesizing 2?-fucosyllactose is obtained by the fusion expression of the fucosyltransferase gene and the L-fucokinase/guanosine 5?-diphosphate-L-fucose pyrophosphorylase gene in Bacillus subtilis BSGL-FF, the fermentation supernatant of which comprises a cumulative amount of 2?-fucosyllactose as high as 1.62 g/L, which is 55% higher than the amount achieved with the control strain. The construction method of the recombinant Bacillus subtilis of the present invention is simple, and convenient to use, and thus has good application prospects.
    Type: Grant
    Filed: December 23, 2020
    Date of Patent: April 5, 2022
    Assignee: JIANGNAN UNIVERSITY
    Inventors: Long Liu, Jian Chen, Xueqin Lv, Guocheng Du, Jianghua Li, Jieying Deng, Ke Liu
  • Patent number: 11286466
    Abstract: Disclosed are ketoreductases and the use thereof. The disclosed ketoreductases are particularly useful for enzymatically catalyzing the reduction of ketones to chiral or non-chiral secondary alcohols and oxidation of chiral or non-chiral secondary alcohols to ketones.
    Type: Grant
    Filed: January 13, 2020
    Date of Patent: March 29, 2022
    Assignee: C-LECTA GMBH
    Inventors: Sabrina Koepke, Sebastian Bartsch, Andreas Vogel
  • Patent number: 11254958
    Abstract: The present invention describes the use of thio-phosphate in the metabolic engineering of E. coli. Thio-phosphate can be used to increase the metabolic flux in important synthetic pathways to enhance the production of bioproducts. The pathways impacted include the following: fatty acid synthesis, isoprenoid syntheses, Vit K2 synthesis, ribonucleotide synthesis, and the synthesis of phosphoribosyl pyrophosphate (PRPP) derivatives like 5-aminoimidazole-4-carboxamide (AICA riboside), histidine, and tryptophan. Thus, thio-phosphate can be used to assist in the production of these molecules and/or their derivatives. Enhanced production of AICA in Bacillus megaterium is also demonstrated.
    Type: Grant
    Filed: May 10, 2019
    Date of Patent: February 22, 2022
    Inventor: Elizabeth Gay Frayne
  • Patent number: 11220691
    Abstract: The present invention describes an approach to produce or increase hypotaurine or taurine production in unicellular organisms. More particularly, the invention relates to genetic modification of unicellular organisms that include bacteria, algal, microalgal, diatoms, yeast, or fungi. The invention relates to methods to increase taurine levels in the cells by binding taurine or decreasing taurine degradation. The invention can be used in organisms that contain native or heterologous (transgenic) taurine biosynthetic pathways or cells that have taurine by enrichment. The invention also relates to methods to increase taurine levels in the cells and to use the said cells or extracts or purifications from the cells that contain the invention to produce plant growth enhancers, food, animal feed, aquafeed, food or drink supplements, animal-feed supplements, dietary supplements, health supplements or taurine.
    Type: Grant
    Filed: July 2, 2020
    Date of Patent: January 11, 2022
    Assignee: PLANT SENSORY SYSTEMS, LLC
    Inventors: Frank J. Turano, Michelle B. Price
  • Patent number: 11214816
    Abstract: The present invention relates to a recombinant microorganism having heterologous genes introduced thereto and a method for producing a useful material from formic acid and carbon dioxide using the microorganism. The present invention provides a novel microorganism having a cyclic metabolic pathway introduced thereto through which C3 or higher carbon organic compounds can be synthesized from formic acid and carbon dioxide, whereby carbon dioxide rich in nature and formic acid that is of low toxicity and suitable for anabolic reaction in view of reaction kinetics and which can be easily and rapidly synthesized from carbon dioxide can be used to effectively synthesize the C3 organic compound pyruvic acid from which various high-value added compound can be synthesized.
    Type: Grant
    Filed: November 20, 2017
    Date of Patent: January 4, 2022
    Assignee: KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
    Inventors: Sang Yup Lee, Junho Bang
  • Patent number: 11208466
    Abstract: A cytochrome b-glucose dehydrogenase fusion protein having modified electron transfer properties, and a glucose measurement method and measuring kit using the cytochrome b-glucose dehydrogenase fusion protein are provided. Provided are a cytochrome b-glucose dehydrogenase fusion protein in which glucose dehydrogenase having homology with SEQ ID NO: 1 or SEQ ID NO: 4 and cytochrome b are linked together, as well as a glucose measurement method, a measurement reagent kit and a sensor using the cytochrome b-glucose dehydrogenase fusion protein. The cytochrome b-glucose dehydrogenase fusion protein of the present invention has modified electron transfer properties, and can be used for measuring glucose in the presence of a free-form mediator in reduced concentration or in the absence of a free-form mediator, and can be used, for example, in continuous glucose monitoring.
    Type: Grant
    Filed: November 30, 2016
    Date of Patent: December 28, 2021
    Assignee: KIKKOMAN CORPORATION
    Inventors: Yosuke Masakari, Seiichi Hara
  • Patent number: 11203790
    Abstract: The present invention relates to glucoamylase variants, polynucleotides encoding the variants, methods of producing the variants, and methods of using the variants. Also described are the use of glucoamylases of the invention for starch conversion to produce fermentation products, such as ethanol, and syrups, such as glucose. The invention also relates to a composition comprising a glucoamylase variant of the invention.
    Type: Grant
    Filed: October 18, 2019
    Date of Patent: December 21, 2021
    Assignee: NOVOZYMES A/S
    Inventors: Shikha Gupta, Allan Svendsen, Vivek Srivastava, Marco Malten, Thomas Agersten Poulsen, Preethi Ramaiya, Beth Nelson, Vasudeva Prahlada Rao, Padmavathi Balumuri
  • Patent number: 11198854
    Abstract: Presented herein are polymerase enzymes for improved incorporation of nucleotide analogues, in particular nucleotides which are modified at the 3? sugar hydroxyl, as well as methods and kits using the same.
    Type: Grant
    Filed: May 22, 2020
    Date of Patent: December 14, 2021
    Assignee: Illumina, Inc.
    Inventors: Erin Bomati, Michael Previte, Matthew William Kellinger, Cheng-Yao Chen, Molly He
  • Patent number: 11186604
    Abstract: Disclosed are steviol glycosides referred to as rebaudioside V and rebaudioside W. Also disclosed are methods for producing rebaudioside M (Reb M), rebausoside G (Reb G), rebaudioside KA (Reb KA), rebaudioside V (Reb V) and rebaudioside (Reb W).
    Type: Grant
    Filed: January 28, 2020
    Date of Patent: November 30, 2021
    Assignee: Conagen Inc.
    Inventors: Guohong Mao, Xiaodan Yu
  • Patent number: 11186850
    Abstract: The present invention describes a recombinant yeast cell functionally expressing one or more heterologous nucleic acid sequences encoding for ribulose-1,5-phosphate carboxylase/oxygenase (EC4.1.1.39; Rubisco), and optionally one or more molecular chaperones for Rubisco, and one or more phosphoribulokinase (EC2.7.1.19; PRK), wherein the phosphoribulokinase is under control of a promoter (the “PRK promoter”) that enables higher expression under anaerobic conditions than under aerobic conditions.
    Type: Grant
    Filed: April 24, 2020
    Date of Patent: November 30, 2021
    Assignee: DSM IP ASSETS B.V.
    Inventors: Ioannis Papapetridis, Antonius Jeroen Adriaan Van Maris, Jacobus Thomas Pronk, Paulus Petrus De Waal, Niels Lauret, Maarten Dirk Verhoeven, Jozef Petrus Johannes Schmitz
  • Patent number: 11180739
    Abstract: Described are a genetically modified microorganism and corresponding methods and products. The genetically modified microorganism may include a first gene that encodes an acyl transferase and a second gene that encodes a peptide or protein. One or both of the first and second gene may be heterologous. The genetically modified microorganism may include a modified acyl-CoA biosynthetic pathway configured for one or more of: inducible biosynthesis of an acyl-CoA and over-accumulation of the acyl-CoA. The genetically modified microorganism may be effective upon fermentation to cause acylation of the peptide or protein by the acyl transferase using the acyl-CoA to provide a N-acylated peptide or protein product.
    Type: Grant
    Filed: February 27, 2018
    Date of Patent: November 23, 2021
    Assignee: Duke University
    Inventors: Michael David Lynch, Romel Menacho Melgar
  • Patent number: 11174452
    Abstract: The present invention relates to compositions comprising protease variants suitable for use in cleaning or detergent compositions, such as laundry detergent compositions and dish wash compositions, including automatic dish wash compositions.
    Type: Grant
    Filed: February 22, 2019
    Date of Patent: November 16, 2021
    Assignee: NOVOZYMES A/S
    Inventors: Peter Kamp Hansen, Esben Peter Friis, Torben Vedel Borchert, Lars Lehmann Hylling Christensen, Jens Erik Nielsen, Maria Berggaard Silow